OriGene Technologies, Inc., a Rockville, MD-based developer of genome wide products for research and diagnostic applications, acquired Acris Antibodies GmbH, a Herford, Germany and San Diego, CA-based provider of antibodies and other life science related products.
The amount of the deal was not disclosed.
Led by Hans-Joachim Soll, Ph.D., General Manager and Founder, Acris Antibodies sells and distributes research antibodies and related life science products to research, diagnostic and biopharmaceutical customers worldwide.
The company, which has 16 employees with operations in Germany and the United States, supplies more than 364,000 antibodies and scientific research products.
The acquisition will ad Acris Antibodies’ antibody offering complements to OriGene’s existing antibody portfolio, expands their capabilities to serve customers for their research antibody needs, and increase demand from European distributors and customers. The company also plans to leverage global reach to bring Acris products to a larger customer base.
Acris will be integrated into OriGene’s antibody business unit.